Endometriosis

TET3 is a common epigenetic immunomodulator of pathogenic macrophages

(pubmed link is pending resumption of service after federal government closing)

TET3-overexpressing macrophages are a unifying pathogenic feature with therapeutic potential in chronic inflammatory diseases

(pubmed link is pending resumption of service after federal government closing)

TET3-overexpressing macrophages promote endometriosis

https://pubmed.ncbi.nlm.nih.gov/39141428/

Targeting TET3 in macrophages provides a concept strategy for the treatment of endometriosis

https://pubmed.ncbi.nlm.nih.gov/39484721/